Compare Public Storage (PSA) vs Tango Therapeutics Inc. (TNGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Public Storage vs Tango Therapeutics Inc. — how do they compare? Public Storage trades at $290.77 (market cap $53.96B), while Tango Therapeutics Inc. trades at $22.5 (market cap $3.74B). The key difference: Public Storage is far larger — about 14.4× Tango Therapeutics Inc.'s market cap, and Public Storage pays a 4.16% dividend while Tango Therapeutics Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Public Storage for 130 Days and Tango Therapeutics Inc. for 0 Days on average.
| PSA | TNGX | |
|---|---|---|
Market Cap | $53.96B | $3.74B |
Volume | 834,787 | 3,438,781 |
Sector | Real Estate | Health |
52-Week High | $330.47 | $32.90 |
52-Week Low | $258.44 | $7.50 |
Typical Hold Time | 130 Days | 0 Days |
Enterprise Value | $68.23B | $2.76B |
Dividend Yield | 4.16% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Public Storage (PSA) trades at $288.39, showing modest daily weakness with a 0.17% decline. The stock maintains strong profitability with 41.8% net income margin and has beaten earnings estimates for three consecutive quarters. Technical indicators show neutral momentum with support at $286 and resistance at $291. Recent developments include the completion of Public Storage Canada acquisition and a $400 million Canadian debt offering, positioning for strategic growth.
PSA offers stable income with a 4.05% dividend yield and improving operational momentum, though valuation multiples appear elevated. Key risks include REIT sector sensitivity to interest rates and competitive pressures. Analyst consensus leans cautious with 64% hold ratings despite a $328 price target suggesting 14% upside potential from current levels.
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Public Storage
Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →
